2025-09-10
24 分钟The Trump administration is making a lot of changes to public health policy,
particularly under the head of Health and Human Services,
Robert F. Kennedy Jr. One of the most contentious areas is around vaccines.
This summer,
Kennedy fired all of the CDC's vaccine advisory panel and has taken heat for what critics say undermines confidence in the system.
And two weeks ago, The White House fired the head of the Centers for Disease Control and Prevention,
reportedly because of disagreements around vaccine approval.
One of the government officials in charge of approving vaccines and who reports into Kennedy's department is Dr. Marty McCary,
the commissioner of the Food and Drug Administration.
In the summer,
McCary's FDA decided to narrow the number of people who are supposed to get this year's COVID booster,
approving it only for people over the age of 65 or with adverse health conditions.
This week,
we sat down with Dr. Marty McCary to talk about how he sees the FDA's role in this moment of vaccine politics and how health officials can rebuild trust at a time when trust in public health policy is at historic lows.
Welcome to The Journal, our show about money, business, and power.
I'm Ryan Knudsen.
It's Tuesday, September 9th.
Coming up on the show, Dr. Marty McCary on the FDA vaccines and trust in public health.
Commissioner Marty McCary, thanks so much for coming back to the podcast.
Great to be with you, Ryan.